Aquaculture microbiology and immune response research explores how microbial management – including the use of probiotics, prebiotics and related biotechnological enhancements – can improve the health ...
SAN DIEGO, Feb. 3, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients have been implanted in a Phase 2 ...
Researchers at MIT and Boston Children's Hospital have published a report today in the journal Nature Materials that provides a better understanding of the body's immune responses to the materials ...
Dr. Walt Cook, a clinical assistant professor in Texas A&M University’s College of Veterinary Medicine and Biomedical Sciences, is part of a team that is working to develop an oral vaccine to combat ...
LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...